Jeffrey S. Conrad
Plus aucun poste en cours
Profil
Mr. Jeffrey S.
Conrad is Secretary & Director at Abviva, Inc. and Partner at eFund Capital Management LLC.
He is on the Board of Directors at Abviva, Inc.
Mr. Conrad also served on the board at Probe Manufacturing, Inc.
He received his undergraduate degree from the University of California, Berkeley and a graduate degree from Loyola Law School.
Anciens postes connus de Jeffrey S. Conrad
| Sociétés | Poste | Fin |
|---|---|---|
| CLEAN ENERGY TECHNOLOGIES, INC. | Directeur/Membre du Conseil | 27/07/2009 |
eFund Capital Management LLC
 eFund Capital Management LLC Investment ManagersFinance eFund Capital Management LLC operated as a private equity fund. The company was headquartered in Long Beach, CA. | Corporate Officer/Principal | - |
Abviva, Inc.
 Abviva, Inc. Medical SpecialtiesHealth Technology Abviva, Inc. develops and commercializes diagnostic and therapeutic products from Mammastatin, a growth-regulatory protein that inhibits breast cancer cell growth. The Mammastatin is normally present in the blood serum of healthy women and absent in women with breast cancer. The company develops breast cancer therapies through internal and external collaborative research with pharmaceutical, biotechnology and leading research institution world wide to commercialize the Mammastatin serum. It was founded on September 19, 1994 and is headquartered in Santa Barbara, CA. | Directeur/Membre du Conseil | - |
Formation de Jeffrey S. Conrad
| University of California, Berkeley | Undergraduate Degree |
| Loyola Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CLEAN ENERGY TECHNOLOGIES, INC. | Producer Manufacturing |
| Entreprise privées | 2 |
|---|---|
Abviva, Inc.
Abviva, Inc. Medical SpecialtiesHealth Technology Abviva, Inc. develops and commercializes diagnostic and therapeutic products from Mammastatin, a growth-regulatory protein that inhibits breast cancer cell growth. The Mammastatin is normally present in the blood serum of healthy women and absent in women with breast cancer. The company develops breast cancer therapies through internal and external collaborative research with pharmaceutical, biotechnology and leading research institution world wide to commercialize the Mammastatin serum. It was founded on September 19, 1994 and is headquartered in Santa Barbara, CA. | Health Technology |
eFund Capital Management LLC
eFund Capital Management LLC Investment ManagersFinance eFund Capital Management LLC operated as a private equity fund. The company was headquartered in Long Beach, CA. | Finance |